AI in Remote Patient Monitoring Market Report 2026

The artificial intelligence (AI) in remote patient monitoring market size has grown exponentially in recent years. It will grow from $2.79 billion in 2025 to $3.45 billion in 2026 at a compound annual growth rate (CAGR) of 23.4%. The growth in the historic period can be attributed to growth in chronic disease prevalence, increasing adoption of telehealth services, expansion of connected medical devices, rising healthcare digitization initiatives, early use of remote monitoring platforms.

The artificial intelligence (AI) in remote patient monitoring market size is expected to see exponential growth in the next few years. It will grow to $8.02 billion in 2030 at a compound annual growth rate (CAGR) of 23.5%. The growth in the forecast period can be attributed to increasing demand for home-based care models, rising investments in ai-powered healthcare analytics, expansion of personalized care pathways, growing integration of rpm with electronic health records, increasing focus on preventive healthcare. Major trends in the forecast period include increasing deployment of AI-enabled predictive monitoring systems, rising adoption of wearable health sensors, growing integration of real-time health analytics platforms, expansion of automated alert and decision support tools, enhanced focus on continuous patient monitoring.

The widespread adoption of telemedicine is expected to drive the growth of artificial intelligence (AI) in the remote patient monitoring market in the coming years. Telemedicine involves the use of telecommunications technologies, such as video calls, phone calls, and online messaging, to deliver medical services remotely. AI in remote patient monitoring, when integrated with telemedicine, analyzes this data in real time, identifying subtle changes and notifying healthcare professionals about potential issues before they escalate into emergencies. For example, in May 2024, according to Eurostat, a Luxembourg-based government agency, 8.5% of individuals in the EU aged 16 to 74 participated in online consultations using the internet in 2023. Thus, the increasing adoption of telemedicine will propel the growth of artificial intelligence (AI) in the remote patient monitoring market.

Major companies in the artificial intelligence (AI) in remote patient monitoring market are emphasizing the integration of AI with wearable devices, such as AI-enabled ambulatory connected patient monitoring systems, to strengthen their competitive edge and enhance healthcare delivery. An AI-enabled ambulatory connected patient monitoring system is a healthcare solution that merges artificial intelligence (AI) with ambulatory monitoring technology to continuously observe and analyze a patient's vital signs and health metrics in real time. For example, in October 2023, Dozee, an India-based medical equipment manufacturer, introduced 'Dozee Pro Ex,' an advanced ambulatory connected patient monitoring system developed for global markets. This made-in-India solution offers wireless wearable sensors for continuous tracking of vital parameters, including ECG rhythm, blood pressure, heart rate, oxygen saturation, respiration rate, and temperature. Importantly, 'Dozee Pro Ex' incorporates an AI-powered early warning system that evaluates trends in vital parameters, providing timely alerts for potential clinical deterioration. This next-generation solution aims to transform traditional healthcare by enabling 24/7 patient monitoring, whether individuals are in a hospital bed, away from the bed, at a healthcare facility, or at home.

In April 2024, Royal Philips, a Netherlands-based health technology company, formed a partnership with SmartQare B.V. to advance remote patient monitoring solutions. Through this collaboration, they aim to create sophisticated remote patient monitoring solutions that enhance patient outcomes and optimize healthcare delivery using integrated digital health technologies. SmartQare B.V., a Netherlands-based healthcare technology company, focuses on wearable health technology solutions and remote patient monitoring services, improving healthcare delivery and patient engagement.

Major companies operating in the artificial intelligence (AI) in remote patient monitoring market are Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, DexCom Inc, Cerner Corporation, Tunstall Healthcare, Connect America LLC, American Well, Biofourmis, Merative L.P., Vivify Health, Current Health, BioIntelliSense, Preventice Solutions, AiCure LLC, Orbita, MobileHelp, EarlySense, Gyant, Myia Labs, Sentrian, Biobeat, ChroniSense Medical Ltd., Somatix Inc., Twistle, HealthWatch Technologies.

North America was the largest region in the artificial intelligence (AI) in remote patient monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in remote patient monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI) in remote patient monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the artificial intelligence in remote patient monitoring market by increasing costs of imported sensors, wearable devices, communication modules, and cloud infrastructure hardware used in AI-enabled monitoring solutions. Healthcare providers in North America and Europe are most affected due to dependence on imported medical electronics, while Asia-Pacific faces pricing pressure on device manufacturing. These tariffs are increasing system deployment costs and slowing large-scale rollouts. At the same time, they are encouraging domestic manufacturing of medical devices, regional sourcing of components, and innovation in software-centric monitoring platforms.

The artificial intelligence (AI) in remote patient monitoring market research report is one of a series of new reports that provides artificial intelligence (AI) in remote patient monitoring market statistics, including artificial intelligence (AI) in remote patient monitoring industry global market size, regional shares, competitors with a artificial intelligence (AI) in remote patient monitoring market share, detailed artificial intelligence (AI) in remote patient monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in remote patient monitoring industry. This artificial intelligence (AI) in remote patient monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence (AI) in remote patient monitoring (RPM) involves the use of AI technologies within systems aimed at observing and managing patients' health and well-being from a distance. AI is utilized to improve the functionality of remote monitoring solutions, offering advanced analytics, automation, and intelligent insights for healthcare providers.

The primary types of solutions in artificial intelligence (AI) for remote patient monitoring include software, hardware, and services. Software encompasses programs and applications developed for data analysis, pattern recognition, and decision support in AI-enabled remote patient monitoring. In AI applications, software processes and interprets data from remote patient monitoring devices, allowing real-time analysis, anomaly detection, and personalized health insights. The products are divided into vital monitors, special monitors, and other products, and are integrated with technologies such as natural language processing, machine learning, querying methods, and speech recognition, which are used in applications like diabetes, respiratory issues, weight management and fitness monitoring, cancer, dehydration, cardiovascular diseases, sleep disorders, viral infections, and other health applications.

The artificial intelligence (AI) in remote patient monitoring market consists of revenues earned by entities by providing services such as data transmission and connectivity, cloud-based storage and hosting, data integration and aggregation, predictive modeling, and clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in remote patient monitoring market also includes sales of wearable devices, remote monitoring platforms, and clinical communication tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.